Search

everythinglearnresearchcommunity

for

Search:↓

Three siblings with a rare genetic condition had abnormal sexual development and chose different gender identities, needing surgery and therapy.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Higher IL-21 levels may help predict alopecia areata activity.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Surgery may help infants with sagittal craniosynostosis develop more typical language processing.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Microneedling with PRP can boost hair growth in certain hair loss conditions.

The Bcl-2 protein is important for keeping hair follicle stem cells working and preventing hair loss.

Shengfu oil speeds up wound healing by reducing inflammation and promoting tissue repair.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

Tet1/2/3 enzymes affect hair follicle cell development by influencing BMP signaling.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Cyclooxygenase-2 overexpression in mice skin causes hair loss like human androgenetic alopecia.

Tiny pollution particles called PM2.5 can harm skin cells by causing stress, damage to cell parts, and cell death.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

A cluster of sulfur-rich hair protein genes was found on chromosome 17.

Post-COVID conditions increase health care needs for six months after infection.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.